Skip to main content
Contact
Search
Keyword
Sign in
Home
Publications
Annals of Long-Term Care
Pharmacy Learning Network
Veterans Health Today
Events
Education
About
Keyword
About
About Pharmacy Learning Network
Advertising
Get Permissions
Publishing Staff
Education
Resources
Commentary
Interviews
News
Podcasts
Videos
Quizzes
Drug Recalls
Topics
Antibiotics
Biosimilars
Infectious Diseases
Opioid Use Disorder
Transplant
Respiratory Syncytial Virus
PharmLaw
Keyword
About
About Pharmacy Learning Network
Advertising
Get Permissions
Publishing Staff
Education
Resources
Commentary
Interviews
News
Podcasts
Videos
Quizzes
Drug Recalls
Topics
Antibiotics
Biosimilars
Infectious Diseases
Opioid Use Disorder
Transplant
Respiratory Syncytial Virus
PharmLaw
News
Risk of IBD with Type 2 Diabetes Treatment
04/12/2018
Opens in a new window
Opens in a new window
Copied to clipboard
<section><h2>Which antidiabetic drug class is most likely to cause inflammatory bowel disease in patients with type 2 diabetes?</h2></section><section><h2>a. dipeptidyl peptidase-4 inhibitors</h2></section><section><h3>b. meglitinides</h3></section><section><h3>c. sulfonylureas</h3></section><section><h3>d. thiazolidinediones</h3></section>
Subscribe Today
Pharmacy Learning Network Newsletter
Brand/Meeting
